DR ANDREW WU is the Co-Founder and CEO of Mesh Bio, a digital health startup providing automation and analytics software solutions built on AI, for the transformation of care delivery. He was previously Chief Operating Officer of Clearbridge Biomedics (now known as Biolidics) where he developed innovative cancer diagnostics technology in the field of liquid biopsy. He was also Chief Product Officer of Clearbridge Health. Both companies are now listed on SGX Catalist. Andrew holds Bachelor’s and Ph.D. degrees in Biochemical Engineering from University College London.
The Power of Prediction: Predictive Analytics in Healthcare
While the aims and vision of healthcare have remained consistent since time immemorial, the healthcare landscape and care delivery have been transformed by technology. New technologies are continuously emerging and there are a plethora of…
